In the BioHarmony Drug Report Database
Allegra, Allegra Hives, Children’s Allegra, Children’s Allegra Hives (fexofenadine) is a small molecule pharmaceutical. Fexofenadine was first approved as Allegra on 1996-07-25. It is used to treat allergic rhinitis perennial and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. Fexofenadine hydrochloride’s patents are valid until 2030-08-02 (FDA).
Image (chem structure or protein)